{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:01:07Z","timestamp":1793278867110,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bcp.2021.114419","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T16:39:31Z","timestamp":1610728771000},"page":"114419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["The role of P2Y receptors in regulating immunity and metabolism"],"prefix":"10.1016","volume":"187","author":[{"given":"Marianna","family":"Lov\u00e1szi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Branco Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8108","authenticated-orcid":false,"given":"P\u00e1l","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Hask\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Do some nerve cells release more than one transmitter?","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2021.114419_b0015","first-page":"225","article-title":"Purine nucleotides","volume":"15","author":"Burnstock","year":"1976","journal-title":"Adv. Biochem. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02008.x","article-title":"Discovery of purinergic signalling, the initial resistance and current explosion of interest","volume":"167","author":"Burnstock","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0026-895X(25)15197-3","article-title":"The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices","volume":"6","author":"Sattin","year":"1970","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"Gen. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0163-7258(94)00048-4","article-title":"Purinoceptors: are there families of P2X and P2Y purinoceptors?","volume":"64","author":"Abbracchio","year":"1994","journal-title":"Pharmacol. Therapeut."},{"issue":"7397","key":"10.1016\/j.bcp.2021.114419_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11010","article-title":"Molecular mechanism of ATP binding and ion channel activation in P2X receptors","volume":"485","author":"Hattori","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2021.114419_b0050","doi-asserted-by":"crossref","unstructured":"I. von K\u00fcgelgen, T.K. Harden, Molecular pharmacology, physiology, and structure of the P2Y receptors, Adv. Pharmacol. (San Diego, Calif.) 61 (2011) 373-415.","DOI":"10.1016\/B978-0-12-385526-8.00012-6"},{"key":"10.1016\/j.bcp.2021.114419_b0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","article-title":"Pharmacology and structure of P2Y receptors","volume":"104","author":"von K\u00fcgelgen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2021.114419_b0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.ai.2017.05.006","article-title":"P2Y Receptors in Immune Response and Inflammation","volume":"136","author":"Le Duc","year":"2017","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purin. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0070","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1073\/pnas.90.11.5113","article-title":"Expression cloning of an ATP receptor from mouse neuroblastoma cells","volume":"90","author":"Lustig","year":"1993","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0026-895X(25)09210-7","article-title":"Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor","volume":"50","author":"Nicholas","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"15","key":"10.1016\/j.bcp.2021.114419_b0085","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.275.15.10767","article-title":"A G protein-coupled receptor for UDP-glucose","volume":"275","author":"Chambers","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1124\/mol.64.5.1210","article-title":"Purification and functional reconstitution of the human P2Y12 receptor","volume":"64","author":"Bodor","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.64.1.104","article-title":"Pharmacological characterization of the human P2Y13 receptor","volume":"64","author":"Marteau","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11302-012-9294-7","article-title":"G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions","volume":"8","author":"Jacobson","year":"2012","journal-title":"Purin. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pharmthera.2005.08.014","article-title":"Pharmacological profiles of cloned mammalian P2Y-receptor subtypes","volume":"110","author":"von K\u00fcgelgen","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1748-1716.2010.02116.x","article-title":"Signalling and pharmacological properties of the P2Y receptor","volume":"199","author":"Harden","year":"2010","journal-title":"Acta Physiol. (Oxford, England)"},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b0120","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1074\/jbc.M301734200","article-title":"Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop","volume":"279","author":"Herold","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11302-016-9514-7","article-title":"A critical look at the function of the P2Y11 receptor","volume":"12","author":"Dreisig","year":"2016","journal-title":"Puriner. Signal."},{"key":"10.1016\/j.bcp.2021.114419_b0130","first-page":"107","article-title":"P2Y11 Receptors: Properties, Distribution and Functions","volume":"Vol. 19","author":"Kennedy","year":"2017"},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0026-895X(24)26501-9","article-title":"ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor","volume":"57","author":"Kennedy","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114419_b0140","doi-asserted-by":"crossref","first-page":"12583","DOI":"10.1074\/jbc.272.19.12583","article-title":"Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos","volume":"272","author":"Bogdanov","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0145","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1021\/jm050955y","article-title":"Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors","volume":"49","author":"Nahum","year":"2006","journal-title":"J. Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2005.09.052","article-title":"Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods","volume":"337","author":"Nonaka","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0155","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1073\/pnas.0303950101","article-title":"The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells","volume":"101","author":"Nirodi","year":"2004","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b0160","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nn.3554","article-title":"The microglial sensome revealed by direct RNA sequencing","volume":"16","author":"Hickman","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2021.114419_b0165","doi-asserted-by":"crossref","unstructured":"E. J\u00e4ger, A. Schulz, V. Lede, C.C. Lin, T. Sch\u00f6neberg, D. Le Duc, Dendritic Cells Regulate GPR34 through Mitogenic Signals and Undergo Apoptosis in Its Absence, J. Immunol. (Baltimore, Md. : 1950) 196(6) (2016) 2504-13.","DOI":"10.4049\/jimmunol.1501326"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/glia.22744","article-title":"Altered microglial phagocytosis in GPR34-deficient mice","volume":"63","author":"Preissler","year":"2015","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni.3253","article-title":"Phagocytosis of apoptotic cells in homeostasis","volume":"16","author":"Arandjelovic","year":"2015","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/cdd.2015.172","article-title":"The clearance of dying cells: table for two","volume":"23","author":"Green","year":"2016","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.cdd.4401517","article-title":"Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release","volume":"12","author":"Monks","year":"2005","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.immuni.2016.02.005","article-title":"Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo","volume":"44","author":"Lee","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0205","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1378\/chest.129.6.1673","article-title":"Burying the Dead: The Impact of Failed Apoptotic Cell Removal (Efferocytosis) on Chronic Inflammatory Lung Disease","volume":"129","author":"Vandivier","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.431","article-title":"Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis","volume":"7","author":"Yin","year":"2016","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b0215","first-page":"2977","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"BBA"},{"issue":"Pt 6","key":"10.1016\/j.bcp.2021.114419_b0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1258\/000456305774538238","article-title":"Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis","volume":"42","author":"Harwood","year":"2005","journal-title":"Ann. Clin. Biochem."},{"issue":"1645","key":"10.1016\/j.bcp.2021.114419_b0225","article-title":"The Role of Efferocytosis in Autoimmune Diseases","volume":"9","author":"Abdolmaleki","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.52","article-title":"Engulfment signals and the phagocytic machinery for apoptotic cell clearance","volume":"49","author":"Park","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0235","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/cdd.2016.13","article-title":"Do not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes","volume":"23","author":"Medina","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2021.114419_b0240","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3389\/fimmu.2019.02670","article-title":"Contribution of Macrophage Efferocytosis to Liver Homeostasis and Disease","volume":"10","author":"Horst","year":"2019","journal-title":"Front. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2021.114419_b0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2009.04.007","article-title":"G2A and LPC: regulatory functions in immunity","volume":"89","author":"Kabarowski","year":"2009","journal-title":"Prostagland. Other Lipid Mediat."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0250","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1096\/fj.08-107169","article-title":"Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a \u201ccome-and-get-me\u201d signal","volume":"22","author":"Gude","year":"2008","journal-title":"FASEB Journal: Off. Publicat. Federat. Am. Soc. Exp. Biol."},{"issue":"7261","key":"10.1016\/j.bcp.2021.114419_b0255","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"issue":"7139","key":"10.1016\/j.bcp.2021.114419_b0260","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114419_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imbio.2010.03.010","article-title":"Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages","volume":"216","author":"Marques-da-Silva","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.bcp.2021.114419_b0270","doi-asserted-by":"crossref","unstructured":"M.R. Elliott, K.M. Koster, P.S. Murphy, Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses, J. Immunol. (Baltimore, Md.: 1950) 198(4) (2017) 1387-1394.","DOI":"10.4049\/jimmunol.1601520"},{"issue":"7317","key":"10.1016\/j.bcp.2021.114419_b0275","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030808","article-title":"ATP Release Channels","volume":"19","author":"Taruno","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2021.114419_b0290","doi-asserted-by":"crossref","unstructured":"Y. Chen, R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P.A. Insel, W.G. Junger, ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors, Science (New York, N.Y.) 314(5806) (2006) 1792-5.","DOI":"10.1126\/science.1132559"},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0295","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2012.08.049","article-title":"Purinergic P2Y\u2082 receptors promote neutrophil infiltration and hepatocyte death in mice with acute liver injury","volume":"143","author":"Ayata","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2021.114419_b0300","doi-asserted-by":"crossref","unstructured":"K.R. Vaughan, L. Stokes, L.R. Prince, H.M. Marriott, S. Meis, M.U. Kassack, C.D. Bingle, I. Sabroe, A. Surprenant, M.K. Whyte, Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor, J. Immunol. (Baltimore, Md. : 1950) 179(12) (2007) 8544-53.","DOI":"10.4049\/jimmunol.179.12.8544"},{"issue":"24","key":"10.1016\/j.bcp.2021.114419_b0305","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1111\/febs.15135","article-title":"PLAG enhances macrophage mobility for efferocytosis of apoptotic neutrophils via membrane redistribution of P2Y2","volume":"286","author":"Kim","year":"2019","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0310","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1523\/JNEUROSCI.21-06-01975.2001","article-title":"Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi\/o-coupled P2Y receptors","volume":"21","author":"Honda","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0315","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/glia.20224","article-title":"Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA","volume":"52","author":"Nasu-Tada","year":"2005","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"issue":"6782","key":"10.1016\/j.bcp.2021.114419_b0325","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/35011175","article-title":"Apoptosis. Gone but not forgotten","volume":"405","author":"Green","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0330","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.92.5.1396","article-title":"Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine","volume":"92","author":"Sambrano","year":"1995","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0335","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20101157","article-title":"Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums","volume":"207","author":"Ravichandran","year":"2010","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0340","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","article-title":"Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte","volume":"123","author":"Gardai","year":"2005","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0350","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0005-2015","article-title":"Myeloid Cell Turnover and Clearance","volume":"4","author":"Janssen","year":"2016","journal-title":"Microbiol. Spectrum"},{"issue":"36","key":"10.1016\/j.bcp.2021.114419_b0355","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0360","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2021.114419_b0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0074-7742(09)85012-5","article-title":"P2Y(6)-Evoked Microglial Phagocytosis","volume":"85","author":"Inoue","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0370","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bcp.2021.114419_b0375","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1182\/blood-2006-03-013334","article-title":"Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states","volume":"108","author":"Krispin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2021.114419_b0380","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3389\/fimmu.2017.01356","article-title":"Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells","volume":"8","author":"Trahtemberg","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2021.114419_b0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02172","article-title":"Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells","volume":"3","author":"Yamaguchi","year":"2014","journal-title":"eLife"},{"issue":"10","key":"10.1016\/j.bcp.2021.114419_b0390","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1096\/fj.08-107458","article-title":"Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function","volume":"22","author":"Csoka","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0395","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2007-01-065870","article-title":"A2A adenosine receptors and C\/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli","volume":"110","author":"Csoka","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0400","first-page":"376","article-title":"Adenosine promotes alternative macrophage activation via A2A and A2B receptors","volume":"26","author":"Csoka","year":"2012","journal-title":"FASEB J. Off. Publicat. Federat. Am. Soc. Exp. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2021.114419_b0405","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hasko","year":"2000","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0410","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hasko","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0415","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/01.CCM.0000206467.19509.C6","article-title":"Adenosine A2A receptor activation reduces lung injury in trauma\/hemorrhagic shock","volume":"34","author":"Hasko","year":"2006","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0420","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1096\/fj.10-155192","article-title":"Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death","volume":"24","author":"Himer","year":"2010","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0425","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.4049\/jimmunol.176.9.5616","article-title":"Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis","volume":"176","author":"Nemeth","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0430","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/db13-0573","article-title":"A2B Adenosine Receptors Prevent Insulin Resistance by Inhibiting Adipose Tissue Inflammation via Maintaining Alternative Macrophage Activation","volume":"63","author":"Csoka","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0435","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.0901295","article-title":"A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation","volume":"185","author":"Csoka","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0440","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.1101224","article-title":"Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process","volume":"188","author":"Koscso","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11302-013-9362-7","article-title":"Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury","volume":"9","author":"Koscso","year":"2013","journal-title":"Purinerg. Signal"},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b0450","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.4049\/jimmunol.175.12.8260","article-title":"Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism","volume":"175","author":"Nemeth","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.chom.2014.02.001","article-title":"A2B Adenosine Receptor Induces Protective Antihelminth Type 2 Immune Responses","volume":"15","author":"Patel","year":"2014","journal-title":"Cell Host Microb."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0460","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(98)00619-0","article-title":"An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice","volume":"358","author":"Hasko","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0465","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.bjp.0702040","article-title":"Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists","volume":"125","author":"Szabo","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0470","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01968999","article-title":"Histamine secretion from mast cells stimulated with ATP","volume":"30","author":"Jaffar","year":"1990","journal-title":"Agents Actions"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0475","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1165\/ajrcmb.20.3.3387","article-title":"ATP modulates anti-IgE-induced release of histamine from human lung mast cells","volume":"20","author":"Schulman","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0480","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.phrs.2010.08.003","article-title":"P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells","volume":"62","author":"Gao","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0485","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2009.10.024","article-title":"UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation","volume":"79","author":"Gao","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11302-012-9325-4","article-title":"The role of P2Y14 and other P2Y receptors in degranulation of human LAD2 mast cells","volume":"9","author":"Gao","year":"2013","journal-title":"Puriner. Signal."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0495","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180458","article-title":"Sorting machineries: how platelet-dense granules differ from \u03b1-granules","volume":"38","author":"Chen","year":"2018","journal-title":"Biosci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0500","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11302-015-9462-7","article-title":"Blood cells: an historical account of the roles of purinergic signalling","volume":"11","author":"Burnstock","year":"2015","journal-title":"Purinerg. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0505","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11302-011-9247-6","article-title":"P2 receptors and platelet function","volume":"7","author":"Hechler","year":"2011","journal-title":"Purinerg. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0510","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11302-012-9303-x","article-title":"P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells","volume":"8","author":"Gachet","year":"2012","journal-title":"Purinerg. Signal."},{"issue":"21","key":"10.1016\/j.bcp.2021.114419_b0515","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0520","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00003495-199754050-00006","article-title":"Clopidogrel","volume":"54","author":"Coukell","year":"1997","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0525","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1074-7613(00)80364-7","article-title":"ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors","volume":"7","author":"Lammas","year":"1997","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0530","first-page":"3626","article-title":"Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing","volume":"29","author":"Cs\u00f3ka","year":"2015","journal-title":"FASEB J. Off. Publicat. Federat. Am. Soc. Exp. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0535","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99431","article-title":"Macrophage P2X4 receptors augment bacterial killing and protect against sepsis","volume":"3","author":"Cs\u00f3ka","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0540","doi-asserted-by":"crossref","first-page":"L890","DOI":"10.1152\/ajplung.00428.2004","article-title":"Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa, American journal of physiology","volume":"289","author":"Geary","year":"2005","journal-title":"Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0545","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SHK.0b013e318160dad4","article-title":"A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis","volume":"30","author":"Inoue","year":"2008","journal-title":"Shock (Augusta, Ga.)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0550","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI17864","article-title":"P2Y12 regulates platelet adhesion\/activation, thrombus growth, and thrombus stability in injured arteries","volume":"112","author":"Andre","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0555","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1160\/TH15-10-0829","article-title":"Studies of the interaction of ticagrelor with the P2Y(13) receptor and with P2Y(13)-dependent pro-platelet formation by human megakaryocytes","volume":"116","author":"Bj\u00f6rquist","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0560","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cmi.2016.56","article-title":"Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0565","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1189\/jlb.1012518","article-title":"LPS-induced systemic inflammation is more severe in P2Y12 null mice","volume":"95","author":"Liverani","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0570","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.116.307401","article-title":"P2Y12 Receptor Modulates Sepsis-Induced Inflammation","volume":"36","author":"Liverani","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0575","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/IAI.00074-10","article-title":"Extracellular ATP and P2Y receptor activation induce a proinflammatory host response in the human urinary tract","volume":"78","author":"S\u00e4ve","year":"2010","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050385","article-title":"Protective role of P2Y2 receptor against lung infection induced by pneumonia virus of mice","volume":"7","author":"Vanderstocken","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0585","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.20101805","article-title":"Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection","volume":"208","author":"S\u00e9ror","year":"2011","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.bcp.2021.114419_b0590","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1128\/JVI.01088-07","article-title":"Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1","volume":"81","author":"H\u00fcbner","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2021.114419_b0595","doi-asserted-by":"crossref","unstructured":"J.E. Hazleton, J.W. Berman, E.A. Eugenin, Purinergic receptors are required for HIV-1 infection of primary human macrophages, J. Immunol. (Baltimore, Md. : 1950) 188(9) (2012) 4488-95.","DOI":"10.4049\/jimmunol.1102482"},{"issue":"10","key":"10.1016\/j.bcp.2021.114419_b0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139805","article-title":"Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response","volume":"10","author":"Muniz","year":"2015","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0605","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1128\/iai.64.11.4706-4713.1996","article-title":"Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation","volume":"64","author":"Ritter","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bcp.2021.114419_b0610","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vph.2016.02.005","article-title":"Increased expression of NTPDases 2 and 3 in mesenteric endothelial cells during schistosomiasis favors leukocyte adhesion through P2Y1 receptors","volume":"82","author":"Oliveira","year":"2016","journal-title":"Vasc.Pharmacol."},{"key":"10.1016\/j.bcp.2021.114419_b0615","unstructured":"WHO, Cardiovascular Diseases www.who.int\/health-topics\/cardiovascular-diseases\/#tab=tab_1."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0620","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global Atlas of Cardiovascular Disease 2000\u20132016: The Path to Prevention and Control","volume":"13","author":"Thomas","year":"2018","journal-title":"Global Heart"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-007-9078-7","article-title":"P2 receptors in cardiovascular regulation and disease","volume":"4","author":"Erlinge","year":"2008","journal-title":"Puriner. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0630","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0635","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2174\/0929867321666141215094050","article-title":"P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease","volume":"22","author":"Ralevic","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0640","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2021.114419_b0645","doi-asserted-by":"crossref","unstructured":"S.P. Kunapuli, J.L. Daniel, P2 receptor subtypes in the cardiovascular system, Biochem. J. 336 (Pt 3)(Pt 3) (1998) 513-23.","DOI":"10.1042\/bj3360513"},{"key":"10.1016\/j.bcp.2021.114419_b0650","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2017.06.010","article-title":"Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases","volume":"180","author":"Nishimura","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0655","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2010-08-263111","article-title":"The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects","volume":"117","author":"Cattaneo","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0660","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0665","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1538-7836.2003.00267.x","article-title":"Signaling events underlying thrombus formation","volume":"1","author":"Jackson","year":"2003","journal-title":"J. Thrombos. Haemost. JTH"},{"issue":"6817","key":"10.1016\/j.bcp.2021.114419_b0670","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0675","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1073\/pnas.91.2.504","article-title":"G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets","volume":"91","author":"Offermanns","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2021.114419_b0680","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_123","article-title":"Role of P2Y(12) Receptor in Thrombosis","volume":"906","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0685","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V91.8.2645.2645_2645_2657","article-title":"Integrin signaling: the platelet paradigm","volume":"91","author":"Shattil","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0690","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.0000085073.69189.88","article-title":"Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects","volume":"108","author":"Fontana","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0695","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","article-title":"Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate","volume":"80","author":"Cattaneo","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0700","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diacare.26.7.2181","article-title":"The platelet in diabetes: focus on prevention of ischemic events","volume":"26","author":"Colwell","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0705","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1160\/TH13-01-0004","article-title":"Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity","volume":"110","author":"Baber","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0710","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1538-7836.2003.00003.x","article-title":"Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice","volume":"1","author":"Hechler","year":"2003","journal-title":"J. Thrombos. Haemost. JTH"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0715","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1358863X07077462","article-title":"Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease","volume":"12","author":"Steinhubl","year":"2007","journal-title":"Vasc. Med. (London, England)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0720","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5482\/HAMO-14-09-0044","article-title":"The platelet P2 receptors in inflammation","volume":"35","author":"Cattaneo","year":"2015","journal-title":"Hamostaseologie"},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0725","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198203043060920","article-title":"Platelet activation and allergic asthma","volume":"306","author":"Gresele","year":"1982","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/TP.0b013e3181938913","article-title":"Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts","volume":"87","author":"Abele","year":"2009","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0735","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/ATVBAHA.111.239095","article-title":"Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0740","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.107.762690","article-title":"Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis","volume":"119","author":"Evans","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114419_b0745","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0750","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CCM.0b013e31819ceb71","article-title":"Platelets support pulmonary recruitment of neutrophils in abdominal sepsis","volume":"37","author":"Asaduzzaman","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcp.2021.114419_b0755","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2017.03.013","article-title":"Purinergic P2Y(6) receptors: A new therapeutic target of age-dependent hypertension","volume":"120","author":"Sunggip","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114419_b0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111385","article-title":"P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development","volume":"9","author":"Garcia","year":"2014","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0765","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2010-10-313957","article-title":"Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation","volume":"117","author":"Riegel","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0770","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ceca.2015.08.004","article-title":"Calcium signaling and the novel anti-proliferative effect of the UTP-sensitive P2Y11 receptor in rat cardiac myofibroblasts","volume":"58","author":"Certal","year":"2015","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0775","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1476-5381.2009.00172.x","article-title":"Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts","volume":"158","author":"Talasila","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0780","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbrc.2013.03.089","article-title":"Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor","volume":"434","author":"Djerada","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114419_b0785","doi-asserted-by":"crossref","unstructured":"J. Balogh, A.K. Wihlborg, H. Isackson, B.V. Joshi, K.A. Jacobson, A. Arner, D. Erlinge, Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors, J. Mol. Cell. Cardiol. 39(2) (2005) 223-30.","DOI":"10.1016\/j.yjmcc.2005.03.007"},{"key":"10.1016\/j.bcp.2021.114419_b0790","unstructured":"WHO, Obesity and overweight www.who.int\/en\/news-room\/fact-sheets\/detail\/obesity-and-overweight, 2016."},{"key":"10.1016\/j.bcp.2021.114419_b0795","unstructured":"M.D. Craig M. Hales, Margaret D. Carroll, M.S.P.H., Cheryl D. Fryar, M.S.P.H., and Cynthia L. Ogden, Ph.D., Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017\u20132018 www.cdc.gov\/nchs\/products\/databriefs\/db360.htm, 2020."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0800","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11302-018-9605-8","article-title":"The involvement of purinergic signalling in obesity","volume":"14","author":"Burnstock","year":"2018","journal-title":"Purinerg. Signal."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0805","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2220\/biomedres.36.115","article-title":"Contribution of extracellular ATP on the cell-surface F1F0-ATP synthase-mediated intracellular triacylglycerol accumulation","volume":"36","author":"Kita","year":"2015","journal-title":"Biomed. Res. (Tokyo, Japan)"},{"issue":"31","key":"10.1016\/j.bcp.2021.114419_b0810","doi-asserted-by":"crossref","first-page":"28556","DOI":"10.1074\/jbc.M411253200","article-title":"Dual roles of P2 purinergic receptors in insulin-stimulated leptin production and lipolysis in differentiated rat white adipocytes","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0815","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1210\/en.2009-1134","article-title":"The purinergic P2Y1 receptor supports leptin secretion in adipose tissue","volume":"151","author":"Laplante","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bcp.2021.114419_b0820","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/scd.2016.0166","article-title":"Mouse P2Y(4) Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation","volume":"26","author":"Lemaire","year":"2017","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0825","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11302-008-9126-y","article-title":"Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion","volume":"4","author":"Richards-Williams","year":"2008","journal-title":"Puriner. Sig."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0830","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s004410100458","article-title":"Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing","volume":"306","author":"Coutinho-Silva","year":"2001","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0835","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MPA.0b013e31815a8473","article-title":"Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells","volume":"36","author":"Silva","year":"2008","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035445","article-title":"Altered metabolic signature in pre-diabetic NOD mice","volume":"7","author":"Madsen","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b0845","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11302-008-9122-2","article-title":"Evidence for the possible involvement of the P2Y(6) receptor in Ca (2+) mobilization and insulin secretion in mouse pancreatic islets","volume":"4","author":"Ohtani","year":"2008","journal-title":"Purinerg. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0850","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2008.03.119","article-title":"Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors","volume":"370","author":"Parandeh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3 Pt 1","key":"10.1016\/j.bcp.2021.114419_b0855","first-page":"E504","article-title":"Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats","volume":"270","author":"Tang","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0860","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/en.2008-1486","article-title":"Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype","volume":"150","author":"Santini","year":"2009","journal-title":"Endocrinology"},{"issue":"48","key":"10.1016\/j.bcp.2021.114419_b0865","doi-asserted-by":"crossref","first-page":"30763","DOI":"10.1073\/pnas.2006578117","article-title":"Lack of adipocyte purinergic P2Y(6) receptor greatly improves whole body glucose homeostasis","volume":"117","author":"Jain","year":"2020","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.bcp.2021.114419_b0870","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bcp.2009.12.026","article-title":"Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells","volume":"79","author":"Balasubramanian","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0875","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00018-009-0191-3","article-title":"ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells","volume":"67","author":"Tan","year":"2010","journal-title":"Cell. Mol. Life Sciences: CMLS"},{"key":"10.1016\/j.bcp.2021.114419_b0880","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-pharmtox-010510-100553","article-title":"Strategies to discover unexpected targets for drugs active at G protein-coupled receptors","volume":"51","author":"Allen","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114419_b0885","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cell.2015.08.032","article-title":"Hypothalamic UDP Increases in Obesity and Promotes Feeding via P2Y6-Dependent Activation of AgRP Neurons","volume":"162","author":"Steculorum","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b0890","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.celrep.2017.01.047","article-title":"Inhibition of P2Y6 Signaling in AgRP Neurons Reduces Food Intake and Improves Systemic Insulin Sensitivity in Obesity","volume":"18","author":"Steculorum","year":"2017","journal-title":"Cell Reports"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0895","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11302-014-9408-5","article-title":"The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss","volume":"10","author":"Voss","year":"2014","journal-title":"Purinerg. Signal."},{"key":"10.1016\/j.bcp.2021.114419_b0900","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fphar.2017.00878","article-title":"Purinergic Receptors in Adipose Tissue As Potential Targets in Metabolic Disorders","volume":"8","author":"Tozzi","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0905","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2302\/kjm.2013-0003-RE","article-title":"Purinergic signalling: pathophysiology and therapeutic potential","volume":"62","author":"Burnstock","year":"2013","journal-title":"Keio J. Med."},{"issue":"17","key":"10.1016\/j.bcp.2021.114419_b0910","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1021\/jm3006355","article-title":"Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist","volume":"55","author":"Yelovitch","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0915","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic Signaling in the Cardiovascular System","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0920","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10557-014-6561-6","article-title":"The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia","volume":"29","author":"Liu","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0925","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/hq0302.105360","article-title":"Purinergic signaling and vascular cell proliferation and death","volume":"22","author":"Burnstock","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0930","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1006\/bbrc.1999.0676","article-title":"MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells","volume":"258","author":"Hou","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"30","key":"10.1016\/j.bcp.2021.114419_b0935","doi-asserted-by":"crossref","first-page":"15841","DOI":"10.1074\/jbc.M115.684118","article-title":"Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy","volume":"291","author":"Clouet","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114419_b0940","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fimmu.2014.00656","article-title":"The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases","volume":"5","author":"Chen","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0945","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12974-017-0795-8","article-title":"Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process","volume":"14","author":"Yang","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0950","doi-asserted-by":"crossref","first-page":"G223","DOI":"10.1152\/ajpgi.00259.2006","article-title":"Upregulation of CD39\/NTPDases and P2 receptors in human pancreatic disease, American journal of physiology","volume":"292","author":"K\u00fcnzli","year":"2007","journal-title":"Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0955","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/s41598-017-02562-x","article-title":"Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6\/SOCE\/Ca(2+)\/\u03b2-catenin Pathway","volume":"7","author":"Wan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0960","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/bbrc.1995.1798","article-title":"Cloning of rat and mouse P2Y purinoceptors","volume":"211","author":"Tokuyama","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0965","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1006\/bbrc.1996.0139","article-title":"Cloning and chromosomal localization of the human P2Y1 purinoceptor","volume":"218","author":"Ayyanathan","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2021.114419_b0970","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.91.8.3275","article-title":"Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy","volume":"91","author":"Parr","year":"1994","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b0975","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)00875-5","article-title":"Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor","volume":"416","author":"Suarez-Huerta","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"52","key":"10.1016\/j.bcp.2021.114419_b0980","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.270.52.30849","article-title":"Cloning and functional expression of a human uridine nucleotide receptor","volume":"270","author":"Communi","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.bcp.2021.114419_b0985","doi-asserted-by":"crossref","first-page":"30845","DOI":"10.1074\/jbc.270.52.30845","article-title":"Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene","volume":"270","author":"Nguyen","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114419_b0990","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3565(24)29509-4","article-title":"Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder","volume":"297","author":"Lazarowski","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b0995","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/bbrc.1996.0739","article-title":"Cloning, functional expression and tissue distribution of the human P2Y6 receptor","volume":"222","author":"Communi","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"51","key":"10.1016\/j.bcp.2021.114419_b1000","doi-asserted-by":"crossref","first-page":"31969","DOI":"10.1074\/jbc.272.51.31969","article-title":"Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase","volume":"272","author":"Communi","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b1005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI12242","article-title":"Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs","volume":"107","author":"Foster","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b1010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(24)12604-1","article-title":"Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor","volume":"60","author":"Takasaki","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b1015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/jpet.301.2.705","article-title":"P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse","volume":"301","author":"Zhang","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b1020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/geno.2001.6662","article-title":"Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs","volume":"78","author":"Freeman","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2021.114419_b1025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fncel.2013.00227","article-title":"Introduction and perspective, historical note","volume":"7","author":"Burnstock","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b1030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114419_b1035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","article-title":"Medicinal chemistry of adenosine, P2Y and P2X receptors","volume":"104","author":"Jacobson","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2021.114419_b1040","doi-asserted-by":"crossref","unstructured":"K.A. Jacobson, S. Costanzi, B.V. Joshi, P. Besada, D.H. Shin, H. Ko, A.A. Ivanov, L. Mamedova, Agonists and antagonists for P2 receptors, Novartis Foundation symposium 276 (2006) 58-68; discussion 68-72, 107-12, 275-81.","DOI":"10.1002\/9780470032244.ch6"},{"key":"10.1016\/j.bcp.2021.114419_b1045","unstructured":"Human Protein Atlas. www.proteinatlas.org."},{"issue":"6220","key":"10.1016\/j.bcp.2021.114419_b1050","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bcp.2021.114419_b1055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/5584_2017_57","article-title":"P2Y(1) Receptors - Properties and Functional Activities","volume":"1051","author":"Bara\u0144ska","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2021.114419_b1060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-8069-10-2","article-title":"Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain","volume":"10","author":"Kwon","year":"2014","journal-title":"Molecular Pain"},{"issue":"2","key":"10.1016\/j.bcp.2021.114419_b1065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1476-5381.2009.00497.x","article-title":"P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice","volume":"159","author":"Guns","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b1070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1398-9995.2010.02426.x","article-title":"The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation","volume":"65","author":"M\u00fcller","year":"2010","journal-title":"Allergy"},{"issue":"21","key":"10.1016\/j.bcp.2021.114419_b1075","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114419_b1080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-5793(00)02306-1","article-title":"P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production","volume":"486","author":"Ferrari","year":"2000","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b1085","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.bmc.2008.05.013","article-title":"Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists","volume":"16","author":"Ko","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114419_b1090","doi-asserted-by":"crossref","unstructured":"D.M. Grbic, E. Degagn\u00e9, C. Langlois, A.A. Dupuis, F.P. Gendron, Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP, J. Immunol. (Baltimore, Md. : 1950) 180(4) (2008) 2659-68.","DOI":"10.4049\/jimmunol.180.4.2659"},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b1095","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/scd.2010.0295","article-title":"Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling","volume":"20","author":"Fruscione","year":"2011","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114419_b1100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10495-013-0948-x","article-title":"Extracellular NAD+ inhibits human neutrophil apoptosis","volume":"19","author":"Pliyev","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2021.114419_b1105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/5584_2017_98","article-title":"Structure, Pharmacology and Roles in Physiology of the P2Y(12) Receptor","volume":"1051","author":"von K\u00fcgelgen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2021.114419_b1110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/5584_2017_91","article-title":"An Update on P2Y(13) Receptor Signalling and Function","volume":"1051","author":"P\u00e9rez-Sen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2021.114419_b1115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2019.04.068","article-title":"Recent progress on the discovery of P2Y(14) receptor antagonists","volume":"175","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b1120","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1172\/JCI61636","article-title":"Purinergic P2Y14 receptor modulates stress-induced hematopoietic stem\/progenitor cell senescence","volume":"124","author":"Cho","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.bcp.2021.114419_b1125","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/leu.2017.254","article-title":"The expression of P2Y14, a purinergic G-protein coupled receptor, defines functionally distinct subpopulations in placenta-derived hematopoietic stem progenitor cells","volume":"31","author":"Kook","year":"2017","journal-title":"Leukemia"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114419_b1130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0169-328X(03)00330-9","article-title":"GPR105, a novel Gi\/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function, Brain research","volume":"118","author":"Moore","year":"2003","journal-title":"Mol. Brain Res."},{"issue":"7","key":"10.1016\/j.bcp.2021.114419_b1135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/1389450115666140519162133","article-title":"The role of P2Y12 receptor and activated platelets during inflammation","volume":"15","author":"Liverani","year":"2014","journal-title":"Curr. Drug Targets"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:18:45Z","timestamp":1757769525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":227,"alternative-id":["S0006295221000150"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114419","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of P2Y receptors in regulating immunity and metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114419"}}